Located in the Dundee Technology Park (Dundee, Scotland) and funded by industrial partners, the Scottish government and private investors, IMSL develops novel “magnetic proteins” based upon the intellectual property licensed exclusively from ITI Scotland.
Dr Eddie Blair - Chief Executive Officer
Eddie has fifteen years experience in the pharmaceutical industry, recently as a
Director of Applied Diagnostics and Surrogates at GlaxoSmithKline.
Dr Jamie Love - Chief Operations Officer
Jamie brings to IMSL ten years of experience in biotech business
development,
marketing, licensing and intellectual property management.